
The clinical efficacy and indications for zzso II zzso zzso hypertension chemotherapy were evaluated as a drug delivery system in 101 patients with advanced zzso The sites of primary tumor studied included stomach zzso zzso zzso colon zzso esophagus zzso zzso duct zzso liver zzso breast zzso and 3 other single zzso zzso four cases had distant zzso zzso zzso zzso liver zzso zzso zzso and lung zzso Additionally, the protocol was used 12 cases as zzso zzso chemotherapy and 15 cases following exploratory zzso The blood pressure was elevated to a level zzso times zzso The regimens used consisted of zzso + zzso zzso zzso zzso and zzso zzso The zzso administered were zzso 7 zzso zzso 14 zzso and zzso 350 zzso The cancer chemotherapy protocol with AT II was repeated for an average of zzso cycles with a 2-3 week zzso The drug concentration in tumor zzso was increased zzso fold by AT II zzso The response rate was zzso zzso 7 and zzso zzso and in those patients with zzso zzso liver and zzso zzso was zzso zzso and zzso zzso The serum levels of tumor markers decreased in 9 zzso zzso symptoms, such as zzso zzso and pain, were zzso The mean survival in patients with distant zzso who responded was zzso days, and in zzso was only zzso days zzso less than zzso The side effects of this therapy were slight, typically being grade 1 and zzso Thus, the zzso agents studied in conjunction with AT II were effective in patients with zzso zzso zzso Additionally, this regimen could be performed safely with minimal side zzso 

